1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Immunogenicity: new trials by email Literature Review of Immunogenicity trials Research Report on Immunogenicity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Influenza Vaccination Strategy for Patients With Hematologic Malignancy High-dose trivalent inactivated influenza vaccine (HD-IIV3), MF59-adjuvanted quadrivalent inactivated influenza vaccine (aIIV4), Standard-dose trivalent inactivated influenza vaccine (SD-IIV3) - Hematologic Neoplasms, Influenza | Phase 3 | Recruiting | Asan Medical Center | 120 | 2025-12-04 | 2026-09-01 |
Hematologic Neoplasms (1) · Influenza, Human (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Infections (1) · Neoplasms (1) · Neoplasms by Site (1) · Orthomyxoviridae Infections (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
South Korea (1)